Induction of cancer neoantigens facilitates development of clinically relevant models for the study of pancreatic cancer immunobiology

Authors

Usman Y Panni, Washington University School of Medicine in St. Louis
Michael Y Chen, Washington University School of Medicine in St. Louis
Felicia Zhang, Washington University School of Medicine in St. Louis
Darren R Cullinan, Washington University School of Medicine in St. Louis
Lijin Li, Washington University School of Medicine in St. Louis
C Alston James, Washington University School of Medicine in St. Louis
Xiuli Zhang, Washington University School of Medicine in St. Louis
S Rogers, Washington University School of Medicine in St. Louis
A Alarcon, Washington University School of Medicine in St. Louis
John M Baer, Washington University School of Medicine in St. Louis
Daoxiang Zhang, Washington University School of Medicine in St. Louis
Feng Gao, Washington University School of Medicine in St. Louis
Christopher A Miller, Washington University School of Medicine in St. Louis
Qingqing Gong, Washington University School of Medicine in St. Louis
Kian-Huat Lim, Washington University School of Medicine in St. Louis
David G DeNardo, Washington University School of Medicine in St. Louis
S Peter Goedegebuure, Washington University School of Medicine in St. Louis
William E Gillanders, Washington University School of Medicine in St. Louis
William G Hawkins, Washington University School of Medicine in St. Louis

Journal

Cancer immunology, immunotherapy

Publication Date

8-1-2023

Volume

72

Issue

8

First Page

2813

Last Page

2827

Document Type

Open Access Publication

DOI

10.1007/s00262-023-03463-x

Rights and Permissions

Panni, U.Y., Chen, M.Y., Zhang, F. et al. Induction of cancer neoantigens facilitates development of clinically relevant models for the study of pancreatic cancer immunobiology. Cancer Immunol Immunother 72, 2813–2827 (2023). https://doi.org/10.1007/s00262-023-03463-x. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Recommended Citation

Panni, Usman Y; Chen, Michael Y; Zhang, Felicia; Cullinan, Darren R; Li, Lijin; James, C Alston; Zhang, Xiuli; Rogers, S; Alarcon, A; Baer, John M; Zhang, Daoxiang; Gao, Feng; Miller, Christopher A; Gong, Qingqing; Lim, Kian-Huat; DeNardo, David G; Goedegebuure, S Peter; Gillanders, William E; and Hawkins, William G, "Induction of cancer neoantigens facilitates development of clinically relevant models for the study of pancreatic cancer immunobiology." Cancer immunology, immunotherapy. 72, 8. 2813 - 2827. (2023).
https://digitalcommons.wustl.edu/oa_4/3051

Department

ICTS (Institute of Clinical and Translational Sciences)

Additional Links

Supplemental material is available for this article at publisher site.